Maybank Kim Eng just released an update w a target price of 40 cts.
1. expect healthy EPS growth for FY17E
2. ophthalmology operations in Malaysia continue to improve from higher patient volume
3. continue to explore M&A opportunities
Above are the main highlights. Pls refer to Maybank Kim Eng report for details.